Items where authors include "Plummer, R"

Article

Jones, R, Plummer, R, Moreno, V et al. (13 more authors) (2023) A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical Cancer Research, 29 (2). pp. 331-340. ISSN 1078-0432

Coen, O, Corrie, P, Marshall, H et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21. 761. ISSN 1471-2407

Twelves, C, Anthoney, A, Savulsky, CI et al. (9 more authors) (2019) A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine. British Journal of Cancer, 120 (6). pp. 579-586. ISSN 0007-0920

Danilenko, M, Stamp, E, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (15 more authors) (2018) Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial. JAMA dermatology, 154 (8). pp. 913-921. ISSN 2168-6068

Clay, GD, Worrall, F, Plummer, R et al. (1 more author) (2018) Organic matter properties of Fennoscandian ecosystems: Potential oxidation of northern environments under future change? Science of The Total Environment, 610-611. pp. 1496-1504. ISSN 0048-9697

Cranston, A, Stocken, DD orcid.org/0000-0001-8031-1738, Stamp, E et al. (7 more authors) (2017) Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial. Trials, 18. 111. ISSN 1745-6215

Sharma, RA, Plummer, R, Stock, JK et al. (36 more authors) (2016) Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology, 13 (10). pp. 627-642. ISSN 1759-4774